Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Cardiorenal protective therapy for CKD: Real world data from the Hellenic Cardiorenal Morbidity Snapshots (HECMOS)

Event: ESC Congress 2025

Topic: Cardiovascular Pharmacotherapy

Session: Improving pharmacotherapy in primary prevention

Access
Like
Thumbnail

Guideline directed medical treatment and comorbidity burden among patients admitted with acute HF decompensation: insights from the HECMOS 2.0

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: In-hospital care of acute heart failure

Access
Like
Thumbnail

Nation-wide use of guideline-directed medical therapies in heart failure across the ejection fraction range: The HECMOS study

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: ePosters in chronic heart failure - pharmacotherapy 6

Access
Like
Thumbnail

Exercise duration as apredictor ofcardiovascular disease in arterial hypertension. Data from a 6-year follow-up study.

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension ePosters

Access
Like
Thumbnail

Comparison of the predictive role of changes in left ventricular mass and arterial stiffness for coronary artery disease in essential hypertension: Data from a 8-year-follow-up study

Event: ESC Congress 2019

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Session: Hypertension mediated target organ damage and hypertension phenotypes

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources